Search Share Prices

AZN News - FTSE 100 dives again but supermarkets defy the trend

The FTSE 100 is down 195 points at 6,510 but even on a day of widescale carnage, there are some bright spots. Pharma stocks are also regarded as defensive investments, which may account for why ...

Read More »

Shore Capital Reiterates “Buy” Rating for AstraZeneca (LON:AZN)

AstraZeneca (LON:AZN)‘s stock had its “buy” rating reaffirmed by research analysts at Shore Capital in a note issued to investors on Friday, ThisIsMoney.Co.Uk reports. Several other equities research ...

Read More »

AstraZeneca (LON:AZN) Given “Buy” Rating at Liberum Capital

AstraZeneca (LON:AZN)‘s stock had its “buy” rating reissued by equities researchers at Liberum Capital in a research note issued on Friday, ThisIsMoney.Co.Uk reports. A number of other equities ...

Read More »

AstraZeneca posts negative results for late-stage bladder cancer treatment

AstraZeneca PLC (LON:AZN) has announced that an already approved treatment was not effective in patients with late-stage bladder cancer. The FTSE 100-listed pharma company was in phase III of trials ...

Read More »

Broker Forecast - UBS issues a broker note on AstraZeneca PLC

StockMarketWire.com - UBS today reaffirms its sell investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 6000p (from 5800p).

Read More »

Related Share Prices